MetaCap

Merck & Company Inc. (MRK)

NYSE: MRKHealth CareBiotechnology: Pharmaceutical PreparationsUSD

133.72+0.91 (+0.69%)

At close: Nov 20, 4:02 PM ET · Delayed 15 min

MRK stock chart

Technical analysis

Key statistics

All statistics
Market cap
$329.65B
P/E (TTM)
135.07
Dividend yield
2.51% ($3.36)
Ex-dividend date
Sep 15, 2026
52-week range
96.06 – 156.92
Day range
133.11 – 137.17
Volume / Avg
15.61M / 9.81M
Beta
—

52-week range

$96.06$156.92

MRK stock today

On Nov 20, MRK ended the session at $133.72, adding $0.91 (0.69%), versus the S&P 500's 3.70% decline. At this level, MRK sits in the middle of its 52-week range of $96.06 to $156.92: 14.8% below the high, set on Aug 25, 2026 and 39.2% above the low. MRK is up 27.0% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 36.8%.

At 135.1x trailing earnings, Merck trades above the peer-group median of 30.9x. Its forward P/E of 14.9x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Merck pays an annual dividend of $3.36 per share, a 2.51% yield at the current price.

Summary generated from market data by MetaCap's automated system. Methodology

About Merck

Company profile

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands.

Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Robert M. Davis J.D.
Headquarters
Rahway, NJ
Employees
73,000
Website
merck.com

Financial highlights

Full financials

In fiscal 2025, Merck generated $65.01 billion in revenue, up 1.3% from fiscal 2024, its 6th consecutive year of revenue growth. Net income was $18.25 billion (+6.6% year over year), for a net margin of 28.1% versus a median of 24.5% in the prior 5 years. Gross margin was 74.8% (down from 76.3%).

Merck annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$65.01B$64.17B$60.12B$59.28B$48.70B
Growth+1.31%+6.74%+1.40%+21.72%+17.31%
Net income$18.25B$17.12B$365.00M$14.52B$13.05B
EPS (diluted)$7.28$6.74$0.14$5.71$5.14

Analyst forecast

Forecast

Consensus (28 analysts)

buy

Avg. price target

$161.53+20.80%

  • Strong buy 5
  • Buy 14
  • Hold 9
  • Sell 0
  • Strong sell 0

Target range

Low $105.00High $186.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Oct 29, 2026
EPS actual vs est.
$2.58 vs $2.12
Surprise
+21.70%

Dividends

Dividend history
Annual dividend
$3.36
Last payment
$0.85
Ex-dividend date
Sep 15, 2026

MRK news

All MRK news

Merck peers

Health Care sector
MRK peer companies
CompanyPrice% ChgMarket capCompare
NVSNovartis AG150.47-0.50%$284.18Bvs MRK
AZNAstraZeneca PLC174.35-0.60%$270.40Bvs MRK
ABTAbbott Laboratories103.00-0.84%$178.39Bvs MRK
NVONovo Nordisk A/S37.82-2.70%$166.69Bvs MRK
PFEPfizer Inc.27.40-0.51%$156.18Bvs MRK
ABBVAbbVie Inc.286.20+0.94%$505.89Bvs MRK
VRTXVertex Pharmaceuticals Incorporated515.02-1.08%$130.58Bvs MRK
BMYBristol-Myers Squibb Company58.80+0.79%$120.19Bvs MRK

Indexes, lists and sector

Merck stock FAQ

What is Merck's stock price today?

MRK last traded at $133.72 as of Nov 20, 4:02 PM EST, up 0.69% on the day. Prices are delayed at least 15 minutes.

Does Merck pay a dividend?

Yes. Merck pays $3.36 per share annually, a 2.51% yield. The most recent dividend of $0.85 had an ex-dividend date of Sep 15, 2026.

What is MRK's P/E ratio?

MRK trades at a trailing P/E ratio of 135.07 and a forward P/E of 14.92, compared with a median of 30.9 for its closest peers.

Is Merck in the S&P 500?

Yes. Merck (MRK) is a constituent of the S&P 500 index.

Who is Merck's CEO?

Mr. Robert M. Davis J.D. is the chief executive officer of Merck & Company Inc., which has about 73,000 employees.

Has MRK ever split its stock?

Yes. The most recent MRK stock split was a 1048-for-1000 split on Jun 3, 2021, one of 6 splits on record.

What is the MRK 52-week high?

The 52-week high for MRK is $156.92 and the 52-week low is $96.06. The stock is currently 14.8% below its high.

Compare MRK